Related Experiment Video
Updated: Jul 4, 2026

Transmitochondrial Cybrid Generation Using Cancer Cell Lines
Published on: March 17, 2023
Tumor cell phenotype is sustained by selective MAPK oxidation in mitochondria
Soledad Galli1, Valeria Gabriela Antico Arciuch, Cecilia Poderoso
1Laboratory of Oxygen Metabolism, University Hospital, University of Buenos Aires, Buenos Aires, Argentina.
Abstract:
Mitochondria are major cellular sources of hydrogen peroxide (H(2)O(2)), the production of which is modulated by oxygen availability and the mitochondrial energy state. An increase of steady-state cell H(2)O(2) concentration is able to control the transition from proliferating to quiescent phenotypes and to signal the end of proliferation; in tumor cells thereby, low H(2)O(2) due to defective mitochondrial metabolism can contribute to sustain proliferation. Mitogen-activated protein kinases (MAPKs) orchestrate signal transduction and recent data indicate that are present in mitochondria and regulated by the redox state. On these bases, we investigated the mechanistic connection of tumor mitochondrial dysfunction, H(2)O(2) yield, and activation of MAPKs in LP07 murine tumor cells with confocal microscopy, in vivo imaging and directed mutagenesis. Two redox conditions were examined: low 1 microM H(2)O(2) increased cell proliferation in ERK1/2-dependent manner whereas high 50 microM H(2)O(2) arrested cell cycle by p38 and JNK1/2 activation. Regarding the experimental conditions as a three-compartment model (mitochondria, cytosol, and nuclei), the different responses depended on MAPKs preferential traffic to mitochondria, where a selective activation of either ERK1/2 or p38-JNK1/2 by co-localized upstream kinases (MAPKKs) facilitated their further passage to nuclei. As assessed by mass spectra, MAPKs activation and efficient binding to cognate MAPKKs resulted from oxidation of conserved ERK1/2 or p38-JNK1/2 cysteine domains to sulfinic and sulfonic acids at a definite H(2)O(2) level. Like this, high H(2)O(2) or directed mutation of redox-sensitive ERK2 Cys(214) impeded binding to MEK1/2, caused ERK2 retention in mitochondria and restricted shuttle to nuclei. It is surmised that selective cysteine oxidations adjust the electrostatic forces that participate in a particular MAPK-MAPKK interaction. Considering that tumor mitochondria are dysfunctional, their inability to increase H(2)O(2) yield should disrupt synchronized MAPK oxidations and the regulation of cell cycle leading cells to remain in a proliferating phenotype.
Insights
Mitochondrial hydrogen peroxide (H(2)O(2)) levels regulate cell proliferation by controlling mitogen-activated protein kinase (MAPK) activity. Tumor cells with defective mitochondria maintain proliferation due to disrupted H(2)O(2) signaling.
Area of Science:
- Cell Biology
- Biochemistry
- Cancer Research
Background:
- Mitochondria are key producers of hydrogen peroxide (H(2)O(2)), influencing cell phenotypes.
- Elevated H(2)O(2) can halt proliferation, while low levels in tumors may sustain it.
- Mitogen-activated protein kinases (MAPKs) are redox-sensitive signaling molecules found in mitochondria.
Purpose of the Study:
- To investigate the link between tumor mitochondrial dysfunction, H(2)O(2) production, and MAPK activation.
- To elucidate the role of H(2)O(2) levels in regulating cell cycle transitions via MAPK signaling.
- To understand how mitochondrial defects contribute to sustained tumor cell proliferation.
Main Methods:
- Confocal microscopy and in vivo imaging of LP07 murine tumor cells.
- Directed mutagenesis to study redox-sensitive cysteine domains in MAPKs.
- Mass spectrometry to analyze MAPK-MAPKK interactions and cysteine oxidation states.
Main Results:
- Low H(2)O(2) (1 microM) promoted proliferation via ERK1/2 activation, while high H(2)O(2) (50 microM) arrested the cell cycle through p38 and JNK1/2.
- MAPK activation and nuclear translocation were dependent on H(2)O(2)-induced oxidation of specific cysteine residues.
- Mutation of ERK2 Cys(214) impaired MEK1/2 binding, caused ERK2 retention in mitochondria, and blocked nuclear signaling.
Conclusions:
- Selective oxidation of MAPK cysteine domains by H(2)O(2) regulates MAPK-MAPKK interactions and subcellular localization.
- Dysfunctional tumor mitochondria fail to produce sufficient H(2)O(2), disrupting MAPK signaling and promoting uncontrolled proliferation.
- Targeting mitochondrial H(2)O(2) production or MAPK redox regulation may offer therapeutic strategies for cancer.
Related Concept Videos
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Abnormal Proliferation
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
MAPK Signaling Cascades
